Jean Dallongeville

Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)

Ian Graham, Dan Atar, Knut Borch‐Johnsen et al. · European Journal of Cardiovascular Prevention & Rehabilitation · 2007 · 1.7K citations

Hypertension, Adult Cardiac Surgery, Preventive Cardiology +27

EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE

Daniel De Backer, K. Borch‐Johnsen, Carlos Brotons et al. · Rational Pharmacotherapy in Cardiology · 2005 · 1.3K citations · Full text

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.

Bart Staels, Ngoc Vu‐Dac, V. A. Kosykh et al. · Journal of Clinical Investigation · 1995 · 408 citations · Full text

Lipid Peroxidation, Redox Biology, Oxidative Stress +17

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.

Ngoc Vu‐Dac, Kristina Schoonjans, V. P. Kosykh et al. · Journal of Clinical Investigation · 1995 · 397 citations · Full text

Cell Culture Systems, Lipid Peroxidation, Hyperlipidemia +26

Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study

José R. Banegas, Esther López‐García, Jean Dallongeville et al. · European Heart Journal · 2011 · 354 citations · Full text